Huge congratulations to Evie and my fellow co-authors on our recent work exploring intratumoral B cells, just published in @Cancer_Cell. Many thanks to @kevlitchfield & @JL_Reading for their hard work and support throughout.
Fantastic paper. One of the clearest articulations that current ML methods *can* solve the TCR specificity problem, if given sufficient data. I remain very surprised at the redundancy of individual positions in epitope sequence without altering T cell activation.
Does cancer #evolution & intra-tumour heterogeneity predict long-term relapse? We tested the evolutionary paradigm in prostate cancer clinical trials with long follow-up, combining genomics with digital histopathology: https://t.co/76aiiba2eP
Another proud PI moment from
June, the lab’s spatial biology guru @andreiinsilico describes the cellular ecosystems regulating T cell surveillance in premalignant lesions during pulmonary carcinogenesis at the @uclcancer conference; all from a blank canvas inside 18 months 👏
Our superstar PhD student @sam__gamble elegantly describing the mechanisms of immune regulation that foster lung cancer development at the roadblock first annual cancer prevention conference @Harvard@CRUKresearch#prevconv24@uclcancer